Skip to main content

Increasing Prevalence of Chronic Diseases To Boost The Enteral Feeding Devices Market

The report "Enteral Feeding Devices Market by Product (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), by Stage (Adult, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospital, Ambulatory Care) - Global Forecast to 2021", The global enteral feeding devices market is expected to reach USD 2.80 Billion by 2021 from USD 2.15 Billion in 2016, at a CAGR of 5.5% from 2016 to 2021.

Browse 221 market data tables with 53 figures spread through 238 pages and in-depth TOC on "Enteral Feeding Devices Market by Product (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), by Stage (Adult, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospital, Ambulatory Care) - Global Forecast to 2021" 

An increasing number of hospitals and ambulatory care settings are adopting enteral nutrition as an effective method of clinical nutrition. In addition, the enteral feeding devices market is witnessing a growing adoption of technologically advanced, user-friendly safety systems that minimize complications such as misconnections, tube dislodgements, aspiration, and tube blockage. Several manufacturers in the enteral feeding devices industry are increasingly adopting patient safety techniques, such as unique connection systems to avoid misconnections of feeding tubes and user friendly features such as portable feeding pumps, programming options, programmable flushing intervals, multiple languages, occlusion pressure alarm options, history of previous feed rates, and screen and program lock-out features to prevent manipulation. Such a trend is expected to promote the greater uptake of technologically advanced enteral feeding devices in the global clinical nutrition industry. However, insufficient reimbursement in developing and underdeveloped countries and complications associated with enteral feeding tubes may restrain the growth of this market during the forecast period of 2016 to 2021.


In this report, the enteral feeding devices market is segmented based on product type, stage, end user, application, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets.

In 2015, North America accounted for the largest share of the global enteral feeding devices market, followed by Europe, Asia-Pacific, and RoW. The large share of North America and Europe in this market is primarily attributed to the development and adoption of innovative, patient-friendly enteral feeding devices integrated with safety features. Also, the presence of major companies in this region improves the accessibility of enteral feeding devices among end users. As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. This is mainly attributed to the continuous efforts of Asian economies towards the development of their respective healthcare sectors. Also, the large number of preterm births in developing countries and the growing geriatric population in Japan are the other factors fueling the demand for enteral feeding devices in this region in the coming years.


The major players in the enteral feeding devices market are Fresenius SE & Co. KGaA (Germany), Halyard Health, Inc. (U.S.), Abbott Laboratories (U.S.), Covidien PLC (Ireland), B. Braun Melsungen AG (Germany), C. R. Bard, Inc. (U.S.), Cook Medical (U.S.), ConMed Corporation (U.S.), Nestlé S.A (Switzerland), and Moog, Inc. (U.S.).

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Article Credit: Healthcare DC
Labels:

Comments

Post a Comment

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...
Post a Comment
Read more

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...
Post a Comment
Read more

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...
Post a Comment
Read more